Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1985 2
1987 1
1988 1
1989 1
1990 1
1992 4
1994 2
1995 2
1996 2
1997 3
1998 3
1999 8
2000 5
2001 7
2002 8
2003 9
2004 6
2005 9
2006 16
2007 12
2008 18
2009 20
2010 32
2011 29
2012 39
2013 50
2014 55
2015 60
2016 64
2017 103
2018 89
2019 36
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

636 results
Results by year
Filters applied: . Clear all
Page 1
A metagenome-wide association study of gut microbiota in type 2 diabetes.
Qin J, et al. Nature 2012. PMID 23023125
Assessment and characterization of gut microbiota has become a major research area in human disease, including type 2 diabetes, the most prevalent endocrine disease worldwide. ...An analysis of 23 additional individuals demonstrated that these gut microbial markers might be useful for classifying type 2 diabetes....
Assessment and characterization of gut microbiota has become a major research area in human disease, including type 2 diabe
Gut microbiota and type 2 diabetes mellitus.
Muñoz-Garach A, et al. Endocrinol Nutr 2016 - Review. PMID 27633134
In recent years, many studies have related gut microbiome to development of highly prevalent diseases such as type 2 diabetes and obesity. ...There are several mechanisms that relate microbiota to the onset of insulin resistance and diabetes, including changes in bowel permeability, endotoxemia, interaction with bile acids, changes in the proportion of brown adipose tissue, and effects associated to use of drugs like metformin. ...
In recent years, many studies have related gut microbiome to development of highly prevalent diseases such as type 2 diabet
The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities.
Brunkwall L and Orho-Melander M. Diabetologia 2017 - Review. PMID 28434033 Free PMC article.
During the last decade, evidence has accumulated to support a role for gut microbiota (analysed from faecal samples) in glycaemic control and type 2 diabetes. ...Thus, the aim of this review is to cover the current and future possibilities and challenges of using the gut microbiota, with its capacity to be modified, in the development of preventive and treatment strategies for hyperglycaemia and type 2 diabetes in humans. ...
During the last decade, evidence has accumulated to support a role for gut microbiota (analysed from faecal samples) in glycaemic control an …
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug.
Wu H, et al. Nat Med 2017 - Clinical Trial. PMID 28530702
Metformin is widely used in the treatment of type 2 diabetes (T2D), but its mechanism of action is poorly defined. Recent evidence implicates the gut microbiota as a site of metformin action. ...
Metformin is widely used in the treatment of type 2 diabetes (T2D), but its mechanism of action is poorly defined. Rece …
Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence?
Sircana A, et al. Curr Diab Rep 2018 - Review. PMID 30215149
PURPOSE OF REVIEW: In the last decade many studies have suggested an association between the altered gut microbiota and multiple systemic diseases including diabetes. In this review, we will discuss potential pathophysiological mechanisms, the latest findings regarding the mechanisms linking gut dysbiosis and type 2 diabetes (T2D), and the results obtained with experimental modulation of microbiota. ...
PURPOSE OF REVIEW: In the last decade many studies have suggested an association between the altered gut microbiota and multiple systemic di …
Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.
Forslund K, et al. Nature 2015. PMID 26633628 Free PMC article.
Our study addresses disease and drug signatures in the human gut microbiome of type 2 diabetes mellitus (T2D). Two previous quantitative gut metagenomics studies of T2D patients that were unstratified for treatment yielded divergent conclusions regarding its associated gut microbial dysbiosis. ...
Our study addresses disease and drug signatures in the human gut microbiome of type 2 diabetes mellitus (T2D). T …
Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.
Sabatino A, et al. Curr Diab Rep 2017 - Review. PMID 28271466
PURPOSE OF THE REVIEW: Diabetes mellitus is a major cause of kidney disease [chronic kidney disease (CKD) and end-stage renal disease (ESRD)] and are both characterized by an increased risk of cardiovascular events. ...In the case of type 2 diabetes mellitus (T2DM), inflammation is mainly a consequence of visceral obesity, while in the case of CKD or ESRD patients on dialysis, inflammation is caused by multiple factors, classically grouped as dialysis-related and non-dialysis-related. ...
PURPOSE OF THE REVIEW: Diabetes mellitus is a major cause of kidney disease [chronic kidney disease (CKD) and end-stage renal …
Role of gut microbiota, bile acids and their cross-talk in the effects of bariatric surgery on obesity and type 2 diabetes.
Liu H, et al. J Diabetes Investig 2018 - Review. PMID 28434196 Free PMC article.
Type 2 diabetes mellitus is becoming increasingly prevalent worldwide, and has become one of the greatest threats to global health. ...Currently, these bariatric operations, such as Roux-en-Y gastric bypass and sleeve gastrectomy, are the most effective procedures for the treatment of obesity and type 2 diabetes mellitus worldwide. ...
Type 2 diabetes mellitus is becoming increasingly prevalent worldwide, and has become one of the greatest threat
The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes.
Aydin Ö, et al. Curr Diab Rep 2018 - Review. PMID 29931613 Free PMC article.
PURPOSE OF REVIEW: The objective of this review is to critically assess the contributing role of the gut microbiota in human obesity and type 2 diabetes (T2D). ...
PURPOSE OF REVIEW: The objective of this review is to critically assess the contributing role of the gut microbiota in human obesity and …
Diet-microbiota interactions as moderators of human metabolism
Sonnenburg JL and Bäckhed F. Nature 2016 - Review. PMID 27383980 Free PMC article.
It is widely accepted that obesity and associated metabolic diseases, including type 2 diabetes, are intimately linked to diet. ...
It is widely accepted that obesity and associated metabolic diseases, including type 2 diabetes, are intimately linked …
636 results
Jump to page
Feedback